2013
DOI: 10.5935/0103-507x.20130017
|View full text |Cite
|
Sign up to set email alerts
|

Defining ventilator-associated pneumonia: a (de) construction concept

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 25 publications
(33 reference statements)
0
11
0
Order By: Relevance
“…VAP incidence varies based on settings and geographical distribution [ 5 ]. Other important factors that may influence the reported rate include: study methodology [ 6 , 7 ], definition criteria (microbiological criteria versus non- microbiological criteria) [ 2 , 8 ], use of VAP prevention bundle programs [ 9 ], and medication practice in different PICUs [ 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…VAP incidence varies based on settings and geographical distribution [ 5 ]. Other important factors that may influence the reported rate include: study methodology [ 6 , 7 ], definition criteria (microbiological criteria versus non- microbiological criteria) [ 2 , 8 ], use of VAP prevention bundle programs [ 9 ], and medication practice in different PICUs [ 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…35 The response to these trends in the medical literature has been one of pervasive skepticism. 26,27,33,[36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51] In fact, VAP experts have pointedly criticized the growing misperception that administrative surveillance methods reflect the true incidence of ventilatorassociated tracheobronchitis/VAP. 29 This skepticism is buttressed by observations that validation studies examining surveillance techniques have found that infection-control surveyors miss almost one third of VAP cases.…”
Section: Socioeconomic Context Of Ventilator-associated Pneumonia Repmentioning
confidence: 99%
“…Its development has significant morbidity, which prolongs the user time in mechanical ventilation, as well as the permanence time in the unit and all the costs related to this period of hospitalization. 7 VAP has incidence rates ranging from 9% to 67%, in addition to prolonging the duration of MV and increasing the days of ICU permanence time, implying in treatment costs and mortality over 50% of the cases. 8 VAP is directly related to ICU permanence time and mechanical ventilation, with a risk of developing 1 to 3% for each day of ventilator stay.…”
Section: Resultsmentioning
confidence: 99%